RHAMNETIN IS A BETTER INHIBITOR OF SARS-COV-2 2'-O-METHYLTRANSFERASE THAN DOLUTEGRAVIR: A COMPUTATIONAL PREDICTION.

African journal of infectious diseases（2022）

引用 3|浏览7

暂无评分

摘要

Rhamnetin showed better inhibitory activity at the target's active site than Dolutegravir.

查看译文

关键词

2’-O-methyltransferase Inhibition,COVID-19,Computational Drug prediction,Coronavirus disease,SARS-CoV-2

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要